Sun Pharmaceutical Industries is scaling new heights. After a setback in the US generic-drugs business, India’s largest drugmaker has gradually moved up the value chain and built a sizeable specialty-drugs business over the last few years. Dilip Shanghvi, founder and managing director of Sun Pharma, with his astute sense of business and passion for science, has dodged critics and patiently created a specialty-drugs portfolio through a string of

( Originally published on Jan 23, 2023 )

By admin

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *